Mercapto and seleno derivatives as inhibitors of nitric oxide sy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514497, 514183, 514634, A61K 3128, A61K 3131, A61K 31155, A61K 3133

Patent

active

059859172

ABSTRACT:
This invention is directed to a pharmacologically acceptable composition for inhibiting nitric oxide synthase in a mammal, which includes a mercapto or seleno derivative and a pharmaceutically acceptable carrier. The invention also concerns a method of inhibiting nitric oxide synthase, selectively inhibiting the inducible isoform of nitric oxide synthase, and treating various conditions where there is an advantage in inhibiting nitric oxide biosynthesis. The method includes the step of administering to a mammal a mercapto or seleno derivative in pure form or in a pharmaceutically acceptable carrier.

REFERENCES:
patent: 5298506 (1994-03-01), Stamler et al.
Khym et al., "Ion Exchange Studies of Transguanylation Reactions. II. . . . and 2-Aminothiazolines or Penthiazolines", Journal of the American Chemical Society, vol. 80, pp. 3342-3349, Jul. 5, 1958.
Doherty et al., "Synthesis of D- and L-2-Aminobutylisothiourea Dihydrobromide Isomers and their Conversion to Guanidothiols, Disulphides, and Thiazolines", Journal of Organic Chemistry, vol. 28, pp. 1339-1342, 1963.
Chemical Abstracts, vol. 82, 1975, p. 12, #164694y, Tumor rejection in experimental animals treated with radioprotective thiols.
Cancer Research, 35. 429-437., Feb. 1975, Tumor Rejection in Experimental Animals Treated with Radioprotective Thiols.
Szabo et al., "Beneficial effects and improved survival in rodent models . . . nitric oxide synthase", Pharmacology, vol. 91, pp. 12472-12476. Dec. 1994.
Southan et al., "Isothioureas: potent inhibitors of nitric oxide synthases . . . selectivity", British Journal of Pharmacology, vol. 114, pp. 510-516, 1995.
Wu et al., "Aminoguanidine attenuates the delayed circulatory failure and . . . shock" British Journal of Pharmacology, vol. 113, pp. 001-007, Paper No. 78594, 1994.
Khym et al., "Ion Exchange Studies of Transguanylation Reactions. I. Rearrangement of S,2-Aminoethylisothiourea . . . Aminothiazoline", Journal of the American Chemical Society, vol. 79, pp. 5663-5666, Nov. 5, 1957.
Doherty et al., "Synthesis of Aminoalkylisothiuronium Salts and their Conversion to Mercaptoalkylguanidines and Thiazolines", Journal of the American Chemical Society, vol. 79, pp. 5667-5671, Nov. 5, 1957.
Chu, S., et al., "Potential Antiradiation Agents. II. Selenium Analogs of 2-Aminoethylisothiouronium Hydrobromide and Related Compounds," Journal of the American Chemical Society, vol. 27, pp. 2899-2901, Aug. 1962.
Hino, T., et al., "Radiation-protective Agents. I. Sutdies on N-Alkylated-2-(2-aminoethyl)thiopseudoureas and 1,1-(Dithioethylene)diguanidines", Chemical & Pharmaceutical Bulletin, vol. 14, No. 11, pp. 1193-1201, Nov. 1966.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mercapto and seleno derivatives as inhibitors of nitric oxide sy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mercapto and seleno derivatives as inhibitors of nitric oxide sy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mercapto and seleno derivatives as inhibitors of nitric oxide sy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1325310

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.